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Background: Ewing’s sarcoma uncommonly arises from extraosseous soft tissue or parenchymal organs.
Primary adrenal Ewing’s Sarcoma, although very rare, is extremely aggressive and commonly fatal.
Case presentation: A 17 year old Pakistani male was referred to the outpatient oncology clinic at our center
with a three month history of concomitant pain, swelling and dragging sensation in the right hypochondrium.
Abdominal examination revealed a large, firm mass in the right hypochondrium extending into the right
lumbar region and epigastrium. His genital exam was unremarkable and there were no stigmata of hepatic
or adrenal disease.
Computed tomography scans revealed a large peripherally enhancing mass in the hepatorenal area, biopsy of
which showed a neoplastic lesion composed of small round blue cells which exhibited abundance of glycogen
and stained diffusely positive for CD99 (MIC2 antigen). Fluorescence in situ hybridization demonstrated gene
rearrangement at chromosome 22q12 which confirmed the diagnosis of Ewing’s sarcoma. Staging scans revealed
pulmonary metastasis and hence he was commenced on systemic chemotherapy.
Conclusion: This case report highlights the importance of keeping Ewing’s sarcoma in mind when a young patient
presents with a large non-functional adrenal mass.
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Ewing sarcoma (ES) and peripheral primitive neu-
roectodermal tumor (PNET) are part of a spectrum
of diseases comprising the Ewing sarcoma family of
tumors (ESFTs) which most commonly arise from
long and flat bones and share similar histologic
and immunohistochemical characteristics [1]. ESFTs
characteristically express CD99 (Mic2 antigen) and
the defining characteristic translocation is t(11;22)
(q24;q12) [1].
Although ES/PNET most commonly develops in
bone and soft tissues, solid organ primaries have been
reported in the past at locations including the paraver-
tebral areas and along the genitourinary tract [2].
The adrenal gland has very rarely been implicated as
the primary site of ESFTs after excluding osseous
disease but has been documented to be an extremely* Correspondence: nauman.zahir@aku.edu
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reproduction in any medium, provided the oraggressive and lethal disease when it does occur [3-8].
ES/PNET arising from the adrenal gland has the po-
tential of being misdiagnosed as a neuroblastoma with
which it shares the morphology of small round blue
cell tumor [9].
We report the case of a young man with ES/PNET
of the adrenal gland. We believe that this is the first
reported case of this rare presentation from our center
and possibly from the country. The case highlights the
importance of having ESFTs in the differential diag-
nosis of a non-functional adrenal mass in order to
make a correct diagnosis, as the management and
prognosis of ESFTs is entirely different from other
possible causes.
Case presentation
A 17 year old Pakistani male was referred to the out-
patient oncology clinic at our center with a three
month history of swelling in the right upper abdomen
with concomitant pain and dragging sensation in the
right hypochondrium. An abdominal ultrasonogramd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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retroperitoneal soft tissue mass of unclear origin.
He was uncomfortable due to moderate pain at his
first clinic visit and though vitally stable, was obviously
pale. In the absence of icterus and pedal edema, abdom-
inal examination revealed a large, firm mass in the right
hypochondrium extending into the right lumbar region
and epigastrium. His genital exam was unremarkable
and there were no stigmata of chronic liver disease or
Cushing’s syndrome.
Considering his age and presentation, a diagnosis of
germ cell tumor was still pursued but relevant tumor
markers were non-contributory although serum lactate
dehydrogenase (LDH) was mildly elevated (714 IU/L).
Computed tomography (CT) scans revealed a large per-
ipherally enhancing and centrally necrotic hypervascular
lesion in the hepatorenal area, arising from the right
adrenal gland (Figure 1). This mass measured appro-
ximately 18.7 × 15.1 × 21.3 cm in anteroposterior, trans-
verse and craniocaudal dimensions, was infiltrating the
liver and was also causing displacement of adjacent
structures to the contralateral side.
In view of an adrenal mass in the absence of related
symptomatology, a CT guided trucut biopsy of the
mass was performed. Sections from the biopsy re-
vealed multiple tiny fragments of tissue showing a
neoplastic lesion arranged in sheets with mono-
morphic small tumor cells containing abundant cyto-
plasm and demonstrating rounded nuclear contours
(Figure 2A and 2B). These cells exhibited abundance
of glycogen as highlighted by the periodic acid-Schiff
(PAS) stain (Figure 2C) and stained diffusely positive
for CD99 (MIC2 antigen) (Figure 2D). Fluorescence
in situ hybridization (FISH) confirmed Ewing sarcoma
region 1 (EWSR1) gene rearrangement at chromo-
some 22q12 (Figure 3) and hence a final diagnosis ofFigure 1 Computed tomography scan of the abdomen at presentatio
section (A) and coronal section (B).ES/PNET was made. A bone scan was performed
which ruled out osseous disease.
Staging workup unfortunately revealed multiple, nodu-
lar metastatic pulmonary deposits. He was subsequently
commenced on chemotherapy following cardiac function
assessment and has now completed seven months of sys-
temic chemotherapy with alternating cycles of vincris-
tine, doxorubicin and cyclophosphamide (VAC) and
ifosfamide and etoposide (IE). He has shown promising
clinical response to systemic treatment with a significant
reduction in the size of the mass and alleviation of
symptoms.Conclusions
ES/PNET occurs more commonly in adolescents with a
peak incidence in the second decade of life, has a slight
male preponderance [10], and typically involves the ex-
tremities and the axial skeleton [2]. Less commonly it
arises in soft tissue (extraosseous Ewing sarcoma, EES)
and rarely in parenchymal organs. Only a few cases of
primary adrenal ES/PNET have been reported in litera-
ture [3-8]. Such is the rarity of the diagnosis that the
possibility is usually not even considered in the differen-
tial diagnosis of an adrenal mass. The same holds true
for our patient whereby more common diagnoses were
being contemplated and the patient underwent staging
workup for ES/PNET only once the biopsy results be-
came available.
Metastatic ES/PNET needs to be considered before a
conclusive diagnosis of primary adrenal disease is made.
Extensive radiological imaging failed to demonstrate
any other site of tumor in our patient’s case and
other causes of small round blue cell tumors were ex-
cluded by an appropriate panel of immunohistochem-
ical stains.n. Large mass arising from the right adrenal gland visible in axial
Figure 2 Photomicrographs of the adrenal neoplasm. Sheets of small rounded uniform cells with scant cytoplasm on H&E staining, as seen at
a magnification of 20X (A) & 40X (B). Tumor cells contain abundant cytoplasmic glycogen as demonstrated on PAS stain (C) and show strong
diffuse membrane reactivity with CD99 (D) on immunohistochemistry.
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have overt metastasis at presentation, ESFTs is postu-
lated to be a systemic disease. Relapse rates are as high
as 80-90% in patients undergoing local therapy alone
and the majority of patients now receive chemotherapy,
usually administered prior to and following local treat-
ment [11]. Multimodality treatment has infact been
shown to be curative even in patients with advanced
disease, although the long-term survival rates are poorer
than for localized disease [11]. Following the sameFigure 3 Ewing sarcoma region 1 (EWSR1) gene rearrangement
at chromosome 22q12 was confirmed by Fluorescence in situ
hybridization (FISH).principle, our patient was commenced on and has now
completed seven months of systemic chemotherapy.
The reporting of this case is of paramount importance
because it adds to the limited number of documented
cases of adrenal ES/PNET in literature and emphasizes
upon the consideration of this rare diagnosis when a
young patient presents with a large non-functional ad-
renal mass. It is true that without a high index of suspi-
cion, the diagnosis can easily be missed.
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